FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024488842> ?p ?o ?g. }

• W3024488842 endingPage "1498.e1" @default.
• W3024488842 startingPage "1489" @default.
• W3024488842 abstract "ObjectiveTranscervical carotid artery stenting (CAS) has emerged as an alternative to transfemoral CAS. An earlier systematic review from our group (n = 12 studies; 739 transcervical CAS procedures [489/739 with flow reversal]) demonstrated that transcervical CAS is a safe procedure associated with a low incidence of stroke and complications. Since then, new studies have been published adding nearly 1600 patients to the literature. We aimed to update our early systematic review and also to perform a meta-analysis to investigate outcomes specifically after transcervical CAS with flow reversal.MethodsAn electronic search of PubMed/MEDLINE, Embase, and the Cochrane databases was carried out to identify studies reporting outcomes after transcervical CAS with flow reversal. Crude event rates for outcomes of interest were estimated by simple pooling of data. A proportion meta-analysis was also performed to estimate pooled outcome rates.ResultsA total of 18 studies (n = 2110 transcervical CAS procedures with flow reversal) were identified. A high technical success (98.25%) and a low mortality rate (0.48%) were recorded. The crude rates of major stroke, minor stroke, transient ischemic attack, and myocardial infarction (MI) were 0.71%, 0.90%, 0.57%, and 0.57%, respectively; a cranial nerve injury occurred in 0.28% of the procedures. A neck hematoma was reported in 1.04% of the procedures, and a carotid artery dissection occurred in 0.76% of the interventions; in 1.09% of the cases, conversion to carotid endarterectomy was required. After a meta-analysis was undertaken, the pooled technical success rate was 98.69% (95% confidence interval [CI], 97.19-99.70). A pooled mortality rate of 0.04% (95% CI, 0.00-0.29) was recorded. The pooled rate of any type of neurologic complications was 1.88 (95% CI, 1.24-2.61), whereas the pooled rates of major stroke, minor stroke, and transient ischemic attack were 0.12% (95% CI, 0.00-0.46), 0.15% (95% CI, 0.00-0.50), and 0.01% (95% CI, 0.00-0.22), respectively. The pooled rate of bradycardia/hypotension was 10.21% (95% CI, 3.99-18.51), whereas the pooled rate of MI was 0.08% (95% CI, 0.00-0.39). A neck hematoma after transcervical CAS was recorded in 1.51% (95% CI, 0.22-3.54) of the procedures; in 0.74% (95% CI, 0.05-1.95) of the interventions, conversion to CEA was required. Finally, a carotid artery dissection during transcervical CAS occurred in 0.47% (95% CI, 0.00-1.38) of the procedures.ConclusionsThis updated systematic review and meta-analysis demonstrated that transcervical CAS with flow reversal is associated with high technical success, almost zero mortality, and low rates of major stroke, minor stroke, MI, and complications." @default.
• W3024488842 created "2020-05-21" @default.
• W3024488842 creator A5012004922 @default.
• W3024488842 creator A5052804775 @default.
• W3024488842 creator A5062838283 @default.
• W3024488842 creator A5080188121 @default.
• W3024488842 date "2020-10-01" @default.
• W3024488842 modified "2023-10-14" @default.
• W3024488842 title "An updated systematic review and meta-analysis of results of transcervical carotid artery stenting with flow reversal" @default.
• W3024488842 cites W127283835 @default.
• W3024488842 cites W1861317230 @default.
• W3024488842 cites W1926919662 @default.
• W3024488842 cites W1984650862 @default.
• W3024488842 cites W1994494439 @default.
• W3024488842 cites W2002825414 @default.
• W3024488842 cites W2003544661 @default.
• W3024488842 cites W2031905385 @default.
• W3024488842 cites W2052318847 @default.
• W3024488842 cites W2057108952 @default.
• W3024488842 cites W2063910271 @default.
• W3024488842 cites W2088725968 @default.
• W3024488842 cites W2094030464 @default.
• W3024488842 cites W2099405599 @default.
• W3024488842 cites W2118922179 @default.
• W3024488842 cites W2126515196 @default.
• W3024488842 cites W2134718715 @default.
• W3024488842 cites W2140121283 @default.
• W3024488842 cites W2140480502 @default.
• W3024488842 cites W2148445320 @default.
• W3024488842 cites W2259075673 @default.
• W3024488842 cites W2333129208 @default.
• W3024488842 cites W2468996569 @default.
• W3024488842 cites W2589024371 @default.
• W3024488842 cites W2624069069 @default.
• W3024488842 cites W2772904872 @default.
• W3024488842 cites W2803655838 @default.
• W3024488842 cites W2804860811 @default.
• W3024488842 cites W2890114903 @default.
• W3024488842 cites W2894587013 @default.
• W3024488842 cites W2906824285 @default.
• W3024488842 cites W2907076578 @default.
• W3024488842 cites W2920044647 @default.
• W3024488842 cites W2920178546 @default.
• W3024488842 cites W2924759690 @default.
• W3024488842 doi "https://doi.org/10.1016/j.jvs.2020.04.501" @default.
• W3024488842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32422272" @default.
• W3024488842 hasPublicationYear "2020" @default.
• W3024488842 type Work @default.
• W3024488842 sameAs 3024488842 @default.
• W3024488842 citedByCount "15" @default.
• W3024488842 countsByYear W30244888422020 @default.
• W3024488842 countsByYear W30244888422021 @default.
• W3024488842 countsByYear W30244888422022 @default.
• W3024488842 countsByYear W30244888422023 @default.
• W3024488842 crossrefType "journal-article" @default.
• W3024488842 hasAuthorship W3024488842A5012004922 @default.
• W3024488842 hasAuthorship W3024488842A5052804775 @default.
• W3024488842 hasAuthorship W3024488842A5062838283 @default.
• W3024488842 hasAuthorship W3024488842A5080188121 @default.
• W3024488842 hasBestOaLocation W30244888421 @default.
• W3024488842 hasConcept C126322002 @default.
• W3024488842 hasConcept C127413603 @default.
• W3024488842 hasConcept C141071460 @default.
• W3024488842 hasConcept C17744445 @default.
• W3024488842 hasConcept C189708586 @default.
• W3024488842 hasConcept C199539241 @default.
• W3024488842 hasConcept C2778333808 @default.
• W3024488842 hasConcept C2779169563 @default.
• W3024488842 hasConcept C2779473830 @default.
• W3024488842 hasConcept C2779582425 @default.
• W3024488842 hasConcept C2780645631 @default.
• W3024488842 hasConcept C2781068581 @default.
• W3024488842 hasConcept C2987047532 @default.
• W3024488842 hasConcept C500558357 @default.
• W3024488842 hasConcept C71924100 @default.
• W3024488842 hasConcept C78519656 @default.
• W3024488842 hasConcept C95190672 @default.
• W3024488842 hasConceptScore W3024488842C126322002 @default.
• W3024488842 hasConceptScore W3024488842C127413603 @default.
• W3024488842 hasConceptScore W3024488842C141071460 @default.
• W3024488842 hasConceptScore W3024488842C17744445 @default.
• W3024488842 hasConceptScore W3024488842C189708586 @default.
• W3024488842 hasConceptScore W3024488842C199539241 @default.
• W3024488842 hasConceptScore W3024488842C2778333808 @default.
• W3024488842 hasConceptScore W3024488842C2779169563 @default.
• W3024488842 hasConceptScore W3024488842C2779473830 @default.
• W3024488842 hasConceptScore W3024488842C2779582425 @default.
• W3024488842 hasConceptScore W3024488842C2780645631 @default.
• W3024488842 hasConceptScore W3024488842C2781068581 @default.
• W3024488842 hasConceptScore W3024488842C2987047532 @default.
• W3024488842 hasConceptScore W3024488842C500558357 @default.
• W3024488842 hasConceptScore W3024488842C71924100 @default.
• W3024488842 hasConceptScore W3024488842C78519656 @default.
• W3024488842 hasConceptScore W3024488842C95190672 @default.
• W3024488842 hasIssue "4" @default.
• W3024488842 hasLocation W30244888421 @default.
• W3024488842 hasOpenAccess W3024488842 @default.
• W3024488842 hasPrimaryLocation W30244888421 @default.

• next